Private Equity
The Pennsylvania Biotechnology Center, a life sciences incubator in the U.S., has launched Hatch BioFund Management, an investment arm to support its early-stage companies. Vladmir Walko will serve as CEO.
4 min read · 24 July 2019
San Francisco-based Replicant, a provider of a conversational AI platform, has raised $7 million in seed funding. The investors included Atomic, Bloomberg Beta, Costanoa Ventures and Norwest Venture Partners.
1 min read · 24 July 2019
Phenomenon, a business transformation agency, has raised an undisclosed amount of funding. The investors were Berggruen Holdings and Sleeping Bear Capital.
1 min read · 24 July 2019
Lindon, Utah-based Opiniion, a customer review and online reputation management company, has raised $1.5 million in funding. RET Ventures led the round.
1 min read · 24 July 2019
Xain, a blockchain and AI startup, has secured an undisclosed amount of funding. The investor was Dominik Schiener, co-founder of IOTA.
3 min read · 24 July 2019
San Mateo, California-based Tile, which operates as a smart location company, today announced the close of its $45 million Series C fundraising round, led by Francisco Partners. Existing investors GGV Capital and Bessemer Venture Partners, as well as new investors Bryant Stibel and Silicon Valley Bank participated in the round. Tile said the funding will be used to grow internationally and expand into new products.
3 min read · 24 July 2019
Menlo Park, California-based Tivic Health Systems, a bioelectronic medical device company that treats chronic conditions, has secured $8 million in funding. The backers included Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital and Skylight Investments.
1 min read · 24 July 2019
Woburn, Massachusetts-based Frequency Therapeutics, a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, has raised $62 million in Series C financing. Perceptive Advisors led the round.
1 min read · 24 July 2019
South San Francisco-based Freenome, a provider of a multiomics platform for early cancer detection through a routine blood draw, has secured $160 million in Series B financing. RA Capital Management and Polaris Partners led the round.
1 min read · 24 July 2019
TScan Therapeutics, which designs therapies that reprogram a patient’s own T cells, has raised over $48 million in Series B financing. TScan's backers included Bessemer Venture Partners, Google Ventures, Longwood Fund and Novartis Venture Fund.
1 min read · 24 July 2019
